Pluri (PLUR) Cash & Equivalents Growth (5y) (2015 - 2025)
Pluri (PLUR) Cash & Equivalents Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Pluri |
20.93 Mn |
21.41 Mn |
86,000.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-9.73% |
| Sep 30, 2025 |
-8.46% |
| Jun 30, 2025 |
-6.55% |
| Mar 31, 2025 |
65.43% |
| Dec 31, 2024 |
66.15% |
| Sep 30, 2024 |
41.59% |
| Jun 30, 2024 |
10.56% |
| Mar 31, 2024 |
62.60% |
| Dec 31, 2023 |
47.92% |
| Sep 30, 2023 |
-9.03% |
| Jun 30, 2023 |
55.55% |
| Mar 31, 2023 |
-5.05% |
| Dec 31, 2022 |
3.45% |
| Sep 30, 2022 |
75.70% |
| Jun 30, 2022 |
19.38% |
| Mar 31, 2022 |
36.20% |
| Dec 31, 2021 |
21.25% |
| Sep 30, 2021 |
20.07% |
| Jun 30, 2021 |
38.61% |
| Mar 31, 2021 |
68.72% |
